A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction.

MLA

Topol, E. J., et al. “A Multicenter, Randomized, Placebo-Controlled Trial of a New Form of Intravenous Recombinant Tissue-Type Plasminogen Activator (Activase) in Acute Myocardial Infarction.” Journal of the American College of Cardiology, vol. 9, no. 6, June 1987, pp. 1205–13. EBSCOhost, https://doi.org/10.1016/s0735-1097(87)80457-6.

APA

Topol, E. J., Morris, D. C., Smalling, R. W., Schumacher, R. R., Taylor, C. R., Nishikawa, A., Liberman, H. A., Collen, D., Tufte, M. E., Grossbard, E. B., & et. al. (1987). A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction. Journal of the American College of Cardiology, 9(6), 1205–1213. https://doi.org/10.1016/s0735-1097(87)80457-6

Chicago

Topol, E J, D C Morris, R W Smalling, R R Schumacher, C R Taylor, A Nishikawa, H A Liberman, et al. 1987. “A Multicenter, Randomized, Placebo-Controlled Trial of a New Form of Intravenous Recombinant Tissue-Type Plasminogen Activator (Activase) in Acute Myocardial Infarction.” Journal of the American College of Cardiology 9 (6): 1205–13. doi:10.1016/s0735-1097(87)80457-6.